Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Oncoimmunology|November 20, 2013
Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccinationAdam J Litterman, Arkadiusz Z Dudek, David A Largaespada
Cancer Immunology Research|May 24, 2014
Antigen-specific culture of memory-like CD8 T cells for adoptive immunotherapyAdam J Litterman, David M Zellmer, Rebecca S LaRue, et al.
Genome Research|June 2, 2019
A massively parallel 3' UTR reporter assay reveals relationships between nucleotide content, sequence conservation, and mRNA destabilizationAdam J Litterman, Robin Kageyama, Olivier Le Tonqueze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013
Profound impairment of adaptive immune responses by alkylating chemotherapyAdam J Litterman, David M Zellmer, Karen L Grinnen, et al.
Cell Reports|September 12, 2019
RNA Binding Protein CELF2 Regulates Signal-Induced Alternative Polyadenylation by Competing with Enhancers of the Polyadenylation MachineryRakesh Chatrikhi, Michael J Mallory, Matthew R Gazzara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2012
Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma modelJohn R Ohlfest, Brian M Andersen, Adam J Litterman, et al.
Genome Biology|January 19, 2024
Compact CRISPR genetic screens enabled by improved guide RNA library cloningSeok-Jin Heo, Lauren D Enriquez, Scot Federman, et al.
Genome Biology|December 8, 2023
GCLiPP: global crosslinking and protein purification method for constructing high-resolution occupancy maps for RNA binding proteinsWandi S Zhu, Adam J Litterman, Harshaan S Sekhon, et al.
Cancer Research|September 13, 2011
Oxygen is a master regulator of the immunogenicity of primary human glioma cellsMichael R Olin, Brian M Andersen, Adam J Litterman, et al.
Plos One|May 2, 2015
Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell ResponsesDanielle N Renner, Fang Jin, Adam J Litterman, et al.
Pageof 2